![Becton, Dickinson and Company Website](https://cdn.finchat.io/103678.png)
Becton, Dickinson and Company
NYSE-BDX
Company Overview
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Name
Becton, Dickinson and Company
CEO
Mr. Thomas E. Polen Jr.
Website
www.bd.com
Sector
Health Care Equipment and Supplies
Year Founded
1897
Profile
Market Cap
$67.42B
EV
$81.43B
Shares Out
289.04M
Revenue
$19.83B
Employees
73,000
Margins
Gross
44.9%
EBITDA
25.77%
Operating
14.23%
Pre-Tax
8.44%
Net
7.13%
FCF
16.24%
Returns (5Yr Avg)
ROA
2.79%
ROTA
14.49%
ROE
6.23%
ROCE
5.79%
ROIC
5.04%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$277.5
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$5,310M
Net Debt
$14.01B
Debt/Equity
0.75
EBIT/Interest
5.81
Growth (CAGR)
Rev 3Yr
1.31%
Rev 5Yr
2.99%
Rev 10Yr
9.04%
Dil EPS 3Yr
-8.65%
Dil EPS 5Yr
11.13%
Dil EPS 10Yr
-0.16%
Rev Fwd 2Yr
4.95%
EBITDA Fwd 2Yr
-4.66%
EPS Fwd 2Yr
7.84%
EPS LT Growth Est
7.22%
Dividends
Yield
—
Payout
74.74%
DPS
$3.76
DPS Growth 3Yr
4.66%
DPS Growth 5Yr
4.21%
DPS Growth 10Yr
5.85%
DPS Growth Fwd 2Yr
3.99%